High Incidence of Antiphospholipid Antibodies in Newly Diagnosed Patients With Lymphoma and a Proposed aPL Predictive Score.
Smith Kungwankiattichai,Yupa Nakkinkun,Weerapat Owattanapanich,Theera Ruchutrakool +3 more
Reads0
Chats0
TLDR
Given that the presence of antiphospholipid (aPL) antibodies has been proposed to be associated with thrombosis in newly diagnosed patients with lymphoma, a prospective cohort study on patients with advanced-stage diffuse large B-cell lymphoma found an aPL predictive score of ≥−1 was predictive of aPL positivity.Abstract:
Given that the presence of antiphospholipid (aPL) antibodies has been proposed to be associated with thrombosis in newly diagnosed patients with lymphoma, we conducted a prospective cohort study on these patients. In all, 154 patients were enrolled. More than half were advanced-stage diffuse large B-cell lymphoma. Approximately one-third (35.7%) of the patients had the presence of aPLs, with single-, double-, and triple-aPL positivities of 29.9%, 5.2%, and 0.6%, respectively. Of the 154 patients, 8 (5.19%) developed symptomatic thrombosis during follow-up. There were no significant differences in the incidences of thrombosis for the aPL-positive and aPL-negative groups (5.5% vs 5.1%; P = 1.000). In a multivariate analysis, patients with male sex and lymphoma stage IV were significant risk factors for aPL positivity, with odds ratio [OR] = 2.22 (95% CI: 1.11-4.45), P = .025, and OR: 2.34 (95% CI: 1.17-4.67), P = .016, respectively. An aPL predictive score of ≥-1 was predictive of aPL positivity, with a sensitivity of 83.6% and specificity of 34.3%.read more
Citations
More filters
Journal ArticleDOI
The Role of Antiphospholipid Antibodies in COVID-19.
TL;DR: In this paper, a review of the role of anti-phospholipid antibodies in the global coronavirus disease 2019 (COVID-19) pandemic is presented.
Journal ArticleDOI
COVID-19 disease and autoimmune disorders: A mutual pathway
TL;DR: COVID-19 and its vaccine may trigger the development of many autoimmune diseases in a predisposed patient, the role of the CO VID-19 vaccine in triggering autoimmune diseases, the factors affecting the severity of COVID- 19 in patients suffering from autoimmune Diseases, and the different ways to minimize the risk of COIDs in patients with autoimmune diseases.
Journal ArticleDOI
Antiphospholipid Antibodies and Lipids in Hematological Malignancies
Sonia Guadalupe Barreno-Rocha,Sandra Guzmán-Silahua,Sinaí-del-Carmen Rodríguez-Dávila,Guadalupe Estela Gavilanez-Chávez,Ernesto Germán Cardona-Muñoz,Carlos Riebeling-Navarro,Benjamín Rubio-Jurado,Arnulfo Hernán Nava-Zavala +7 more
TL;DR: This review on antiphospholipid antibodies in hematological neoplasms describes their clinical relationship as future implications at the prognostic level for survival and even treatment.
Book ChapterDOI
The prothrombotic state in cancer.
Benjamín Rubio-Jurado,Lluvia Sugey Sosa-Quintero,Sandra Guzmán-Silahua,Eduardo García-Luna,Carlos Riebeling-Navarro,Arnulfo Hernán Nava-Zavala +5 more
TL;DR: It is necessary to identify these mediators to facilitate treatment and improve outcomes and activation of the coagulation cascade is related to these phenomena through molecules that interact in these processes.
Journal ArticleDOI
Anticardiolipin Autoantibodies as Useful Biomarkers for the Prediction of Mortality in Septic Patients
Amal Abouda,Z Hajjej,Arnauld Mansart,W. Kaabechi,D. E. Mahmoud,O. Lamine,Ezzedine Ghazouani,Mustapha Ferjani,Iheb Labbene +8 more
TL;DR: The data showed that antiphospholipid was useful biomarkers for the prediction of mortality in critically ill septic patients and found a positive correlation between SOFA score and antiph phospholipids antibodies.
References
More filters
Journal ArticleDOI
Antiphospholipid syndrome: Clinical and immunologic manifestations and patterns of disease expression in a cohort of 1,000 patients
Ricard Cervera,J.C. Piette,Josep Font,Munther A. Khamashta,Yehuda Shoenfeld,María Teresa Camps,Søren Jacobsen,Gabriella Lakos,Angela Tincani,Irene Kontopoulou-Griva,Mauro Galeazzi,Pier Luigi Meroni,Ronald H. W. M. Derksen,Philip G. de Groot,Erika Gromnica-Ihle,Marta Baleva,Marta Mosca,Stefano Bombardieri,Frédéric Houssiau,Jean-Christophe Gris,Isabelle Quéré,Eric Hachulla,Carlos Vasconcelos,B. Roch,Antonio Fernández-Nebro,Marie Claire Boffa,Graham R. V. Hughes,Miguel Ingelmo +27 more
TL;DR: An association with SLE, the patient's sex, and the patient’s age at disease onset can modify the disease expression and define specific subsets of APS.
Journal ArticleDOI
Risk factors for chemotherapy-associated venous thromboembolism in a prospective observational study
TL;DR: The incidence of venous thromboembolism (VTE) is increased in cancer, but little information is available about risk factors in cancer patients on chemotherapy.
Journal ArticleDOI
Monoclonal immunoglobulin M lambda coagulation inhibitor with phospholipid specificity. Mechanism of a lupus anticoagulant.
TL;DR: The concept that platelets, rather than phospholipid micelles, are the primary locus of prothrombin and Factor X activation in normal hemostasis is supported.
Journal ArticleDOI
Efficacy of the antiphospholipid score for the diagnosis of antiphospholipid syndrome and its predictive value for thrombotic events
Kotaro Otomo,Tatsuya Atsumi,Olga Amengual,Yuichiro Fujieda,Masaru Kato,Kenji Oku,Tetsuya Horita,Shinsuke Yasuda,Takao Koike +8 more
TL;DR: The aPL-S is a useful quantitative index for diagnosing antiphospholipid syndrome and may be a predictive marker for thrombosis in autoimmune diseases.
Journal ArticleDOI
Prevalence of lupus anticoagulant and anticardiolipin antibodies in a healthy population
TL;DR: In a healthy population LA is found predominantly in younger females and neither LA or ACA appear to identify subjects with other autoimmune parameters such as ANA or Rh factor or, for that matter, each other.